好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

SIAXI: Efficacy and safety of Xeomin (incobotulinumtoxinA) for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: Results of a Phase III, placebo-controlled, randomized, double-blind study
Aging and Dementia
S2 - (-)
007
Authors/Disclosures
Wolfgang Jost
PRESENTER 		Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbive. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. Wolfgang Jost has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial.
Andrzej Friedman, MD (Klinika Neurolog 11, UL Ban-) No disclosure on file
No disclosure on file
No disclosure on file
Janos Csikós No disclosure on file
Andrew Blitzer, MD No disclosure on file